Epperly Melissa B, sold $1.2M of Roivant Sciences (ROIV)

Executed Mar 16, disclosed Mar 18, 2 days later.

Value, as filed

$1.2M

41,861 sh × $28.68

Executed

Mar 16

the trade date, as filed

Disclosed

Mar 18

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

EB Epperly Melissa B, Director profile →

Epperly Melissa B, (Director) filed 4 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 4 sales), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $1.2M of ROIV (41,861 sh × $28.68, as filed), executed Mar 16.

The name

ROIV

Roivant Sciences Ltd. ROIV · Healthcare · 74 filings in 24 months ticker →

Healthcare · Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicine…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Epperly Melissa B, in ROIV

ROIVSALE Roivant Sciences Ltd. $608K
16,850 sh × $36.08
Exec Oct 1
Filed Oct 5 · 6:05 PM ET ROIVSALE Roivant Sciences Ltd. $172K
4,338 sh × $39.65
Exec Sep 15
Filed Sep 17 · 6:43 PM ET ROIVSALE Roivant Sciences Ltd. $515K
15,002 sh × $34.32
Exec Jun 29
Filed Jul 1 · 6:34 PM ET